drugset / Trial / NCT05053321

Reduction of Demoralization in Patients With Tardive Dyskinesia After Treatment With Valbenazine

NCT05053321

NaSingle-groupOpen-labelTreatment

Summary

This will be an Investigator-initiated pilot study in which participants will be assessed with various scales to measure demoralization, anxiety, depression, and subjective incompetence at baseline and every two weeks after treatment with Valbenazine for a total of 6 weeks. Improvement in TD will be assessed as well and correlated with reduction in demoralization.

Timeline

Start
2024-10-18
Primary completion
2025-10-18
Completion
2025-10-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Valbenazine Small molecule

Indications